Alpha Pro Tech vs Myomo
APT and MYO side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How APT and MYO compare
Alpha Pro Tech is the larger company, worth 1.3 times as much as Myomo ($63.9M against $49.5M).
Myomo grew revenue faster over the last twelve months (9.3% versus 7.8% for Alpha Pro Tech).
Alpha Pro Tech keeps more of each dollar of sales as profit, with a net margin of 8.1% compared with −33.1% at Myomo.
Alpha Pro Tech scores higher on the StockData Score (18 against 5 for Myomo), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | APT | MYO |
|---|---|---|
| Size and price | ||
| Market cap | $63.9M | $49.5M |
| Share price | $6.26 | $1.25 |
| Change, 1 year | 31.5% | 36.3% |
| Change, 5 years | 19.2% | −85.5% |
| Beta (5Y) | 0.55 | 1.40 |
| Employees | 122 | 184 |
| StockData Score | ||
| Total score | 18 (better) | 5 |
| Valuation score | 6 (better) | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 4 (better) | 1 |
| Health score | 6 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 12.3× | – |
| P/S | 1.0× (better) | 1.1× |
| P/B | 1.0× (better) | 18.0× |
| EV/EBITDA | 5.9× | – |
| P/FCF | 7.1× | – |
| PEG | 1.48 | – |
| FCF yield | 14.2% (better) | −13.7% |
| Fair value | $10.08 | – |
| Margin of safety | 37.9% | – |
| Growth | ||
| Revenue growth (TTM) | 7.8% | 9.3% (better) |
| Revenue growth, 5Y average | −10.5% | 40.1% (better) |
| Net income growth (TTM) | 40.0% | – |
| EPS growth (TTM) | 50.0% | – |
| EPS growth, 5Y average | −29.7% | – |
| Profitability | ||
| Gross margin | 38.6% | 70.1% (better) |
| Operating margin | 8.7% (better) | −21.8% |
| Net margin | 8.1% (better) | −33.1% |
| FCF margin | 14.2% (better) | −14.9% |
| Return on equity | 8.0% (better) | −174% |
| Return on invested capital | 10.2% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.65 (better) |
| Current ratio | 8.71 (better) | 1.92 |
| Altman Z-score | 5.53 (better) | −3.65 |
| Piotroski F-score | 4 (better) | 3 |
| Dividends and buybacks | ||
| Buyback yield | 1.9% | – |
| Shareholder yield | 1.9% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 29.9% | 30.8% |
| Held by insiders | 17.3% | 16.3% |
| Insider net buying, 12 months | −$570K | $203K (better) |
| Short interest, % of float | 0.89% | 3.5% |
Go deeper
- APT stock overview
- APT income statement
- APT valuation and score
- MYO stock overview
- MYO income statement
- MYO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.